Testing effectiveness (Phase 2)Active Not RecruitingNCT06232655What this trial is testingCladribine Venetoclax in Monocytic AMLWho this might be right forAcute Myeloid Leukemia University of Colorado, Denver 10
Early research (Phase 1)Looking for participantsNCT04318678What this trial is testingCD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)Who this might be right forAML/MDSB-ALLT-ALL+1 more St. Jude Children's Research Hospital 108
Post-approval studies (Phase 4)Active Not RecruitingNCT05144243What this trial is testingStudy to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in ChinaWho this might be right forAcute Myeloid Leukemia (AML) AbbVie 44
Testing effectiveness (Phase 2)Looking for participantsNCT07008638What this trial is testingPhase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid LeukemiaTP53 Masonic Cancer Center, University of Minnesota 32
Not applicableLooking for participantsNCT07165535What this trial is testingQuality of Life and Care Organization of Patients With Chronic Myeloid Leukemia in the Lombardy Hematology NetworkWho this might be right forChronic Myeloid Leukemia (CML) University of Milano Bicocca 2,000
Post-approval studies (Phase 4)Study completedNCT01041040What this trial is testingLAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloblastic Leukemia PETHEMA Foundation 200
Not applicableEnded earlyNCT02435550What this trial is testingICare for Cancer PatientsWho this might be right forMyelodysplastic SyndromesAcute Myeloid LeukemiaAcute Myelogenous Leukemia+4 more University of Florida 136
Testing effectiveness (Phase 2)Study completedNCT01154816What this trial is testingAlisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or LeukemiaWho this might be right forHepatoblastomaPreviously Treated Childhood RhabdomyosarcomaRecurrent Childhood Acute Lymphoblastic Leukemia+8 more Children's Oncology Group 118
Not applicableStudy completedNCT02662933What this trial is testingInvestigating the Relationship Between Physical Function, Comorbidity and Cytogenetic Risk Group in Older Adults With Acute Myelogenous Leukemia (AML)Who this might be right forACUTE MYELOGENOUS LEUKEMIA Wake Forest University Health Sciences 82
Not applicableUnknownNCT03251352What this trial is testingTKI Discontinuation in CML Patients of ChinaWho this might be right forLeukemiaMyelogenousChronic+2 more Shenzhen Second People's Hospital 98
Large-scale testing (Phase 3)Study completedNCT06211452What this trial is testingComparison of Consolidation Strategies for Pediatric Patients With Acute Myeloid LeukemiaWho this might be right forAMLPediatric AML Grupo Argentino de Tratamiento de la Leucemia Aguda 258
Testing effectiveness (Phase 2)Looking for participantsNCT05564390What this trial is testingMYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)Who this might be right forAcute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative NeoplasmAcute Myeloid Leukemia Post Cytotoxic Therapy+2 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT05436418What this trial is testingThe Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell TransplantationWho this might be right forPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell Transplantation National Cancer Institute (NCI) 260
Not applicableEnded earlyNCT01463410What this trial is testingAccuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfilerWho this might be right forAcute Myeloid Leukemia (AML)Acute Promyelocytic Leukemia (APL)Refractory Anemia With Excess of Blasts (RAEB) Skyline Diagnostics BV 264
Early research (Phase 1)Ended earlyNCT02047149What this trial is testingEvaluating the Safety of Zileuton (Zyflo®) in Combination With Dasatinib (Sprycel®) in Chronic Myelogenous LeukemiaWho this might be right forChronic Myelogenous Leukemia University of Massachusetts, Worcester 2
Not applicableNot Yet RecruitingNCT07762508What this trial is testingVABu Conditioning Regimen in Allo-HSCT for AML PatientsWho this might be right forLeukemia, Myeloid, Acute(AML)Hematopoietic Stem Cell Transplantation (HSCT) The First Affiliated Hospital of Soochow University 42
Testing effectiveness (Phase 2)Ended earlyNCT00129948What this trial is testingStudy for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)Who this might be right forLeukemia, Myeloid, Acute SGX Pharmaceuticals, Inc. 211
Early research (Phase 1)Ended earlyNCT00907517What this trial is testingStudy of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247)Who this might be right forMyelogenous Leukemia, AcuteLeukemia, Lymphocytic, AcuteLeukemia, Lymphoblastic, Acute, Philadelphia-Positive+1 more Merck Sharp & Dohme LLC 24
Early research (Phase 1)Looking for participantsNCT06372717What this trial is testingInvestigate APL-4098 Alone and in Combination in Adults With AML or MDSWho this might be right forAcute Myeloid Leukemia RefractoryMyelodysplastic Syndrome Acute Myeloid LeukemiaMyelodysplastic Syndrome With Excess Blasts+2 more Apollo Therapeutics Ltd 100
Testing effectiveness (Phase 2)Study completedNCT00849147What this trial is testingBone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)Who this might be right forPrecursor B-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteBurkitt Lymphoma+3 more Medical College of Wisconsin 55